Center-Authored Papers

Filters: Author is Titus, Linda J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
September 2012
Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.  2012.  Postoophorectomy estrogen use and breast cancer risk.. Obstetrics and gynecology. 120(1):27-36. Abstract
Public Health Sciences Division
Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K.  2013.  Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.. Breast cancer research : BCR. 15(5):R99. Abstract
Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.  2012.  Postoophorectomy estrogen use and breast cancer risk.. Obstetrics and gynecology. 120(1):27-36. Abstract
Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC.  2013.  Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(16):1939-46. Abstract
Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA.  2014.  Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies.. Breast cancer research and treatment. Abstract
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2012.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). Abstract
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract
Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Newcomb PA.  2013.  The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk.. Breast cancer research and treatment. 140(2):427-34. Abstract
Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM et al..  2014.  Reproductive windows, genetic loci, and breast cancer risk.. Annals of epidemiology. 24(5):376-82. Abstract
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG et al..  2012.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.. The lancet oncology. 13(4):385-394. Abstract
November 2013
Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K.  2013.  Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.. Breast cancer research : BCR. 15(5):R99. Abstract
November 2012
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2012.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). Abstract
May 2014
Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM et al..  2014.  Reproductive windows, genetic loci, and breast cancer risk.. Annals of epidemiology. 24(5):376-82. Abstract
May 2013
Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC.  2013.  Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(16):1939-46. Abstract
March 2013
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract
March 2012
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG et al..  2012.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.. The lancet oncology. 13(4):385-394. Abstract
Center-Authored Paper
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract
August 2013
Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Newcomb PA.  2013.  The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk.. Breast cancer research and treatment. 140(2):427-34. Abstract
April 2014
Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA.  2014.  Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies.. Breast cancer research and treatment. Abstract
2014
Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA.  2014.  Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies.. Breast cancer research and treatment. Abstract
Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM et al..  2014.  Reproductive windows, genetic loci, and breast cancer risk.. Annals of epidemiology. 24(5):376-82. Abstract
2013
Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC.  2013.  Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(16):1939-46. Abstract
Warren Andersen S, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.  2013.  Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.. Menopause (New York, N.Y.). 20(3):354-8. Abstract